Global and China Covid-19 Treatment Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 22-Jan-2022
No. of pages: 171
Inquire Before Buying

Market Analysis and Insights: Global Covid-19 Treatment Market

This report focuses on global and China Covid-19 Treatment market.

In 2020, the global Covid-19 Treatment market size was US$ 14443.97 million and it is expected to reach US$ 63.59 million by the end of 2027, with a CAGR of -59.26% during 2021-2027. In China the Covid-19 Treatment market size is expected to grow from US$ 175.22 million in 2020 to US$ 1.35 million by 2027, at a CAGR of -36.52% during the forecast period.

Global Covid-19 Treatment Scope and Market Size

Covid-19 Treatment market is segmented by players, region (country), by Type, and By Application. Players, stakeholders, and other participants in the global Covid-19 Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and By Application in terms of revenue and forecast for the period 2016-2027.

By Company

- Cadila Healthcare

- Johnson & Johnson

- ImmunoPrecise

- Novartis

- Cipla

- Bayer

- Regeneron Pharmaceuticals

- Ascletis Pharma

- GlaxoSmithKline

- Gilead Sciences

- Pharmstandard

- Fujifilm Holdings

- Zhejiang Hisun Pharmaceutical Co. Ltd

- Roche

- Sanofi

- Pfizer

- Eli Lilly

Segment by Type

- Life Support

- Antiviral Medicine

- Antibody Treatments

- Other

Segment by Application

- Children

- Adult

By Region

- North America

- United States

- Canada

- Mexico

- Asia-Pacific

- China

- Japan

- South Korea

- Southeast Asia

- India

- Rest of Asia- -

- Europe

- Germany

- France

- U.K.

- Italy

- Russia

- Rest of Europe

- South America

- Brazil

- Rest of South America

- Middle East & Africa

- Middle East

- Africa

Global and China Covid-19 Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Covid-19 Treatment Market Size Growth Rate by Type: 2020 VS 2021 VS 2027 1
1.2.2 Life Support 3
1.2.3 Antiviral Medicine 4
1.2.4 Antibody Treatments 5
1.3 Market by Application 5
1.3.1 Global Covid-19 Treatment Market Share by Application: 2020 VS 2021 VS 2027 6
1.3.2 Children 7
1.3.3 Adult 8
1.4 Study Objectives 8
1.5 Years Considered 9
2 GLOBAL GROWTH TRENDS 10
2.1 Global Covid-19 Treatment Market Perspective (2016-2027) 10
2.2 Covid-19 Treatment Growth Trends by Regions 11
2.2.1 Covid-19 Treatment Market Size by Regions: 2020 VS 2021 VS 2027 11
2.2.2 Covid-19 Treatment Historic Market Size by Regions (2016-2021) 13
2.2.3 Covid-19 Treatment Forecasted Market Size by Regions (2022-2027) 13
2.2.4 China Covid-19 Treatment Market Share in Global Market 2016-2027 15
2.3 Covid-19 Treatment Industry Dynamic 15
2.3.1 Covid-19 Treatment Market Trends 15
2.3.2 Covid-19 Treatment Market Drivers 16
2.3.3 Covid-19 Treatment Market Challenges 17
2.3.4 Covid-19 Treatment Market Restraints 18
2.3.5 Market Use Cases 18
3 COMPETITION LANDSCAPE BY KEY PLAYERS 20
3.1 Global Top Covid-19 Treatment Players by Revenue 20
3.1.1 Global Top Covid-19 Treatment Players by Revenue (2020-2021) 20
3.1.2 Global Covid-19 Treatment Revenue Market Share by Players (2020-2021) 21
3.2 Global Covid-19 Treatment by Company Type (Tier 1, Tier 2, and Tier 3) 22
3.3 Players Covered: Ranking by Covid-19 Treatment Revenue 23
3.4 Global Covid-19 Treatment Market Concentration Ratio 24
3.4.1 Global Covid-19 Treatment Market Concentration Ratio (CR5 and HHI) 24
3.4.2 Global Top 5 Companies by Covid-19 Treatment Revenue in 2020 25
3.5 Covid-19 Treatment Key Players Head office and Area Served 26
3.6 Key Players Covid-19 Treatment Product Solution and Service 26
3.7 Founded Date of Covid-19 Treatment Company 27
3.8 Therapeutics in Development 28
3.9 Mergers & Acquisitions, Expansion Plans 70
4 COVID-19 TREATMENT BREAKDOWN DATA BY TYPE 73
4.1 Global Covid-19 Treatment Historic Market Size by Type (2016-2021) 73
4.2 Global Covid-19 Treatment Forecasted Market Size by Type (2022-2027) 74
5 COVID-19 TREATMENT BREAKDOWN DATA BY APPLICATION 75
5.1 Global Covid-19 Treatment Historic Market Size by Application (2016-2021) 75
5.2 Global Covid-19 Treatment Forecasted Market Size by Application (2022-2027) 75
6 NORTH AMERICA 77
6.1 North America Covid-19 Treatment Market Size (2016-2027) 77
6.2 North America Covid-19 Treatment Market Size by Type (2016-2021) 77
6.3 North America Covid-19 Treatment Market Size by Application (2016-2021) 78
6.4 North America Covid-19 Treatment Market Size by Country (2016-2021) 79
6.4.1 United States 80
6.4.2 Canada 81
6.4.3 Mexico 81
7 EUROPE 82
7.1 Europe Covid-19 Treatment Market Size (2016-2027) 82
7.2 Europe Covid-19 Treatment Market Size by Type (2016-2021) 82
7.3 Europe Covid-19 Treatment Market Size by Application (2016-2021) 83
7.4 Europe Covid-19 Treatment Market Size by Country (2016-2021) 83
7.4.1 Germany 84
7.4.2 France 85
7.4.3 U.K. 85
7.4.4 Italy 86
7.4.5 Russia 86
8 ASIA-PACIFIC 87
8.1 Asia-Pacific Covid-19 Treatment Market Size (2016-2027) 87
8.2 Asia-Pacific Covid-19 Treatment Market Size by Type (2016-2021) 87
8.3 Asia-Pacific Covid-19 Treatment Market Size by Application (2016-2021) 88
8.4 Asia-Pacific Covid-19 Treatment Market Size by Region (2016-2021) 88
8.4.1 China 89
8.4.2 Japan 90
8.4.3 South Korea 91
8.4.4 Southeast Asia 92
8.4.5 India 93
9 SOUTH AMERICA 94
9.1 South America Covid-19 Treatment Market Size (2016-2027) 94
9.2 South America Covid-19 Treatment Market Size by Type (2016-2021) 94
9.3 South America Covid-19 Treatment Market Size by Application (2016-2021) 95
9.4 South America Covid-19 Treatment Market Size by Country (2016-2021) 96
9.4.1 Brazil 96
10 MIDDLE EAST & AFRICA 97
10.1 Middle East & Africa Covid-19 Treatment Market Size (2016-2027) 97
10.2 Middle East & Africa Covid-19 Treatment Market Size by Type (2016-2021) 97
10.3 Middle East & Africa Covid-19 Treatment Market Size by Application (2016-2021) 98
10.4 Middle East & Africa Covid-19 Treatment Market Size by Country (2016-2021) 99
10.4.1 Middle East 99
10.4.2 Africa 100
11 KEY PLAYERS PROFILES 101
11.1 Cadila Healthcare 101
11.1.1 Cadila Healthcare Company Details 101
11.1.2 Cadila Healthcare Description and Business Overview 101
11.1.3 Cadila Healthcare Covid-19 Treatment Introduction 102
11.1.4 Covid-19 Impact to Cadila Healthcare 102
11.1.5 Revenue in Covid-19 Treatment Business (2020-2021) 103
11.2 Johnson & Johnson 103
11.2.1 Johnson & Johnson Company Details 103
11.2.2 Johnson & Johnson Description and Business Overview 104
11.2.3 Johnson & Johnson Covid-19 Treatment Introduction 104
11.2.4 Covid-19 Impact to Johnson & Johnson 105
11.2.5 Revenue in Covid-19 Treatment Business (2020-2021) 106
11.3 ImmunoPrecise 106
11.3.1 ImmunoPrecise Company Details 106
11.3.2 ImmunoPrecise Description and Business Overview 107
11.3.3 ImmunoPrecise Covid-19 Treatment Introduction 107
11.3.4 Covid-19 Impact to ImmunoPrecise 107
11.3.5 Revenue in Covid-19 Treatment Business (2020-2021) 108
11.4 Novartis 108
11.4.1 Novartis Company Details 108
11.4.2 Novartis Description and Business Overview 109
11.4.3 Novartis Covid-19 Treatment Introduction 109
11.4.4 Covid-19 Impact to Novartis 110
11.4.5 Revenue in Covid-19 Treatment Business (2020-2021) 110
11.5 Cipla 111
11.5.1 Cipla Company Details 111
11.5.2 Cipla Description and Business Overview 111
11.5.3 Cipla Covid-19 Treatment Introduction 112
11.5.4 Covid-19 Impact to Cipla 112
11.5.5 Revenue in Covid-19 Treatment Business (2020-2021) 113
11.6 Bayer 113
11.6.1 Bayer Company Details 113
11.6.2 Bayer Description and Business Overview 114
11.6.3 Bayer Covid-19 Treatment Introduction 114
11.6.4 Covid-19 Impact to Bayer 115
11.6.5 Revenue in Covid-19 Treatment Business (2020-2021) 115
11.7 Regeneron Pharmaceuticals 116
11.7.1 Regeneron Pharmaceuticals Company Details 116
11.7.2 Regeneron Pharmaceuticals Description and Business Overview 116
11.7.3 Regeneron Pharmaceuticals Covid-19 Treatment Introduction 117
11.7.4 Covid-19 Impact to Regeneron Pharmaceuticals 117
11.7.5 Revenue in Covid-19 Treatment Business (2020-2021) 118
11.8 Ascletis Pharma 118
11.8.1 Ascletis Pharma Company Details 118
11.8.2 Ascletis Pharma Description and Business Overview 119
11.8.3 Ascletis Pharma Covid-19 Treatment Introduction 120
11.8.4 Covid-19 Impact to Ascletis Pharma 120
11.8.5 Revenue in Covid-19 Treatment Business (2020-2021) 121
11.9 GlaxoSmithKline 121
11.9.1 GlaxoSmithKline Company Details 121
11.9.2 GlaxoSmithKline Description and Business Overview 121
11.9.3 GlaxoSmithKline Covid-19 Treatment Introduction 122
11.9.4 Covid-19 Impact to GlaxoSmithKline 122
11.9.5 Revenue in Covid-19 Treatment Business (2020-2021) 123
11.10 Gilead Sciences 123
11.10.1 Gilead Sciences Company Details 123
11.10.2 Gilead Sciences Description and Business Overview 124
11.10.3 Gilead Sciences Covid-19 Treatment Introduction 124
11.10.4 Covid-19 Impact to Gilead Sciences 125
11.10.5 Revenue in Covid-19 Treatment Business (2020-2021) 125
11.11 Pharmstandard 125
11.11.1 Pharmstandard Company Details 125
11.11.2 Pharmstandard Description and Business Overview 126
11.11.3 Pharmstandard Covid-19 Treatment Introduction 126
11.11.4 Revenue in Covid-19 Treatment Business (2020-2021) 127
11.12 Fujifilm Holdings 127
11.12.1 Fujifilm Holdings Company Details 127
11.12.2 Fujifilm Holdings Description and Business Overview 128
11.12.3 Fujifilm Holdings Covid-19 Treatment Introduction 128
11.12.4 Covid-19 Impact to Fujifilm Holdings 129
11.12.5 Revenue in Covid-19 Treatment Business (2020-2021) 129
11.13 Hisun Pharma 130
11.13.1 Hisun Pharma Company Details 130
11.13.2 Hisun Pharma Description and Business Overview 130
11.13.3 Hisun Pharma Covid-19 Treatment Introduction 131
11.13.4 Covid-19 Impact to Hisun Pharma 131
11.13.5 Revenue in Covid-19 Treatment Business (2020-2021) 132
11.14 Roche 132
11.14.1 Roche Company Details 132
11.14.2 Roche Description and Business Overview 133
11.14.3 Roche Covid-19 Treatment Introduction 133
11.14.4 Covid-19 Impact to Roche 134
11.14.5 Revenue in Covid-19 Treatment Business (2020-2021) 136
11.15 Sanofi 136
11.15.1 Sanofi Company Details 136
11.15.2 Sanofi Description and Business Overview 136
11.15.3 Sanofi Covid-19 Treatment Introduction 137
11.15.4 Covid-19 Impact to Sanofi 138
11.15.5 Revenue in Covid-19 Treatment Business (2020-2021) 141
11.16 Pfizer 141
11.16.1 Pfizer Company Details 141
11.16.2 Pfizer Description and Business Overview 142
11.16.3 Pfizer Covid-19 Treatment Introduction 142
11.16.4 Covid-19 Impact to Pfizer 143
11.16.5 Revenue in Covid-19 Treatment Business (2020-2021) 143
11.17 Eli Lilly 144
11.17.1 Eli Lilly Company Details 144
11.17.2 Eli Lilly Description and Business Overview 144
11.17.3 Eli Lilly Covid-19 Treatment Introduction 145
11.17.4 Revenue in Covid-19 Treatment Business (2020-2021) 145
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 147
13 APPENDIX 149
13.1 Research Methodology 149
13.1.1 Methodology/Research Approach 149
13.1.2 Data Source 152
13.2 Disclaimer 155
13.3 Author Details 156
List of Tables
Table 1. Global Covid-19 Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2021 VS 2027 2
Table 2. Global Covid-19 Treatment Market Size Growth by Application (US$ Million): 2020 VS 2021 VS 2027 6
Table 3. Global Covid-19 Treatment Market Size by Regions (US$ Million): 2020 VS 2021 VS 2027 11
Table 4. Global Covid-19 Treatment Market Size by Regions (2016-2021) & (US$ Million) 13
Table 5. Global Covid-19 Treatment Market Share by Regions (2016-2021) 13
Table 6. Global Covid-19 Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) 13
Table 7. Global Covid-19 Treatment Market Share by Regions (2022-2027) 14
Table 8. Covid-19 Treatment Market Trends 15
Table 9. Covid-19 Treatment Market Drivers 16
Table 10. Covid-19 Treatment Market Challenges 17
Table 11. Covid-19 Treatment Market Restraints 18
Table 12. Market Use Cases 18
Table 13. Global Covid-19 Treatment Revenue by Players (2020-2021) & (US$ Million) 20
Table 14. Global Covid-19 Treatment Market Share by Players (2020-2021) 21
Table 15. Global Top Covid-19 Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Treatment as of 2020) 23
Table 16. Ranking of Global Top Covid-19 Treatment Companies by Revenue (US$ Million) in 2020 23
Table 17. Global 5 Largest Players Market Share by Covid-19 Treatment Revenue (CR5 and HHI) & (2020-2021) 25
Table 18. Key Players Headquarters and Area Served 26
Table 19. Key Players Covid-19 Treatment Product Solution and Service 26
Table 20. Founded Date of Covid-19 Treatment Company 27
Table 21. Therapeutics in Development 28
Table 22. Selected Pending Acquisitions in Healthcare 70
Table 23. The Global IPO Window Closed Quickly in Early March 2020 72
Table 24. Global Covid-19 Treatment Market Size by Type (2016-2021) & (US$ Million) 73
Table 25. Global Covid-19 Treatment Revenue Market Share by Type (2016-2021) 73
Table 26. Global Covid-19 Treatment Forecasted Market Size by Type (2022-2027) & (US$ Million) 74
Table 27. Global Covid-19 Treatment Revenue Market Share by Type (2022-2027) 74
Table 28. Global Covid-19 Treatment Market Size by Application (2016-2021) & (US$ Million) 75
Table 29. Global Covid-19 Treatment Revenue Market Share by Application (2016-2021) 75
Table 30. Global Covid-19 Treatment Forecasted Market Size by Application (2022-2027) & (US$ Million) 75
Table 31. Global Covid-19 Treatment Revenue Market Share by Application (2022-2027) 76
Table 32. North America Covid-19 Treatment Market Size by Type (2016-2021) & (US$ Million) 77
Table 33. North America Covid-19 Treatment Market Share by Type (2016-2021) 78
Table 34. North America Covid-19 Treatment Market Size by Application (2016-2021) & (US$ Million) 78
Table 35. North America Covid-19 Treatment Market Share by Application (2016-2021) 78
Table 36. North America Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million) 79
Table 37. North America Covid-19 Treatment Market Share by Country (2016-2021) 79
Table 38. Europe Covid-19 Treatment Market Size by Type (2016-2021) & (US$ Million) 82
Table 39. Europe Covid-19 Treatment Market Share by Type (2016-2021) 83
Table 40. Europe Covid-19 Treatment Market Size by Application (2016-2021) & (US$ Million) 83
Table 41. Europe Covid-19 Treatment Market Share by Application (2016-2021) 83
Table 42. Europe Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million) 83
Table 43. Europe Covid-19 Treatment Market Share by Country (2016-2021) 84
Table 44. Asia-Pacific Covid-19 Treatment Market Size by Type (2016-2021) & (US$ Million) 87
Table 45. Asia-Pacific Covid-19 Treatment Market Share by Type (2016-2021) 88
Table 46. Asia-Pacific Covid-19 Treatment Market Size by Application (2016-2021) & (US$ Million) 88
Table 47. Asia-Pacific Covid-19 Treatment Market Share by Application (2016-2021) 88
Table 48. Asia-Pacific Covid-19 Treatment Market Size by Region (2016-2021) & (US$ Million) 88
Table 49. Asia-Pacific Covid-19 Treatment Market Share by Region (2016-2021) 89
Table 50. South America Covid-19 Treatment Market Size by Type (2016-2021) & (US$ Million) 94
Table 51. South America Covid-19 Treatment Market Share by Type (2016-2021) 95
Table 52. South America Covid-19 Treatment Market Size by Application (2016-2021) & (US$ Million) 95
Table 53. South America Covid-19 Treatment Market Share by Application (2016-2021) 95
Table 54. South America Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million) 96
Table 55. South America Covid-19 Treatment Market Share by Country (2016-2021) 96
Table 56. Middle East & Africa Covid-19 Treatment Market Size by Type (2016-2021) & (US$ Million) 97
Table 57. Middle East & Africa Covid-19 Treatment Market Share by Type (2016-2021) 98
Table 58. Middle East & Africa Covid-19 Treatment Market Size by Application (2016-2021) & (US$ Million) 98
Table 59. Middle East & Africa Covid-19 Treatment Market Share by Application (2016-2021) 98
Table 60. Middle East & Africa Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million) 99
Table 61. Middle East & Africa Covid-19 Treatment Market Share by Country (2016-2021) 99
Table 62. Cadila Healthcare Company Details 101
Table 63. Cadila Healthcare Description and Business Overview 101
Table 64. Cadila Healthcare Covid-19 Treatment Product 102
Table 65. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 103
Table 66. Johnson & Johnson Company Details 103
Table 67. Johnson & Johnson Description and Business Overview 104
Table 68. Johnson & Johnson Covid-19 Treatment Product 104
Table 69. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 106
Table 70. ImmunoPrecise Company Details 106
Table 71. ImmunoPrecise Description and Business Overview 107
Table 72. ImmunoPrecise Covid-19 Treatment Product 107
Table 73. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 108
Table 74. Novartis Company Details 108
Table 75. Novartis Description and Business Overview 109
Table 76. Novartis Covid-19 Treatment Product 109
Table 77. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 110
Table 78. Cipla Company Details 111
Table 79. Cipla Description and Business Overview 111
Table 80. Cipla Covid-19 Treatment Product 112
Table 81. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 113
Table 82. Bayer Company Details 113
Table 83. Bayer Description and Business Overview 114
Table 84. Bayer Covid-19 Treatment Product 114
Table 85. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 115
Table 86. Regeneron Pharmaceuticals Company Details 116
Table 87. Regeneron Pharmaceuticals Description and Business Overview 116
Table 88. Regeneron Pharmaceuticals Covid-19 Treatment Product 117
Table 89. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 118
Table 90. Ascletis Pharma Company Details 118
Table 91. Ascletis Pharma Description and Business Overview 119
Table 92. Ascletis Pharma Covid-19 Treatment Product 120
Table 93. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 121
Table 94. GlaxoSmithKline Company Details 121
Table 95. GlaxoSmithKline Description and Business Overview 121
Table 96. GlaxoSmithKline Covid-19 Treatment Product 122
Table 97. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 123
Table 98. Gilead Sciences Company Details 123
Table 99. Gilead Sciences Description and Business Overview 124
Table 100. Gilead Sciences Covid-19 Treatment Product 124
Table 101. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 125
Table 102. Pharmstandard Company Details 125
Table 103. Pharmstandard Description and Business Overview 126
Table 104. Pharmstandard Covid-19 Treatment Product 126
Table 105. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 127
Table 106. Fujifilm Holdings Company Details 127
Table 107. Fujifilm Holdings Description and Business Overview 128
Table 108. Fujifilm Holdings Covid-19 Treatment Product 128
Table 109. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 129
Table 110. Hisun Pharma Company Details 130
Table 111. Hisun Pharma Description and Business Overview 130
Table 112. Hisun Pharma Covid-19 Treatment Product 131
Table 113. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 132
Table 114. Roche Company Details 132
Table 115. Roche Description and Business Overview 133
Table 116. Roche Covid-19 Treatment Product 133
Table 117. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 136
Table 118. Sanofi Company Details 136
Table 119. Sanofi Description and Business Overview 136
Table 120. Sanofi Covid-19 Treatment Product 137
Table 121. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 141
Table 122. Pfizer Company Details 141
Table 123. Pfizer Description and Business Overview 142
Table 124. Pfizer Covid-19 Treatment Product 142
Table 125. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 143
Table 126. Eli Lilly Company Details 144
Table 127. Eli Lilly Description and Business Overview 144
Table 128. Eli Lilly Covid-19 Treatment Product 145
Table 129. Revenue in Covid-19 Treatment Business (2020-2021) & (US$ Million) 145
Table 130. Research Programs/Design for This Report 149
Table 131. Key Data Information from Secondary Sources 153
Table 132. Key Data Information from Primary Sources 154
List of Figures
Figure 1. Global Covid-19 Treatment Market Share by Type: 2021 2
Figure 2. Global Covid-19 Treatment Market Share by Type: 2027 3
Figure 3. Life Support Features 4
Figure 4. Antiviral Medicine Features 5
Figure 5. Global Covid-19 Treatment Market Share by Application: 2021 6
Figure 6. Global Covid-19 Treatment Market Share by Application: 2027 7
Figure 7. Children Case Studies 7
Figure 8. Adult Case Studies 8
Figure 9. Covid-19 Treatment Report Years Considered 9
Figure 10. Global Covid-19 Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 10
Figure 11. Global Covid-19 Treatment Market Size, (US$ Million), 2020 VS 2021 VS 2027 11
Figure 12. Global Covid-19 Treatment Market Share by Regions: 2021 12
Figure 13. Global Covid-19 Treatment Market Share by Regions: 2027 12
Figure 14. Global Covid-19 Treatment Market Share by Regions (2022-2027) 14
Figure 15. China Covid-19 Treatment Market Share in Global Market 2016-2027 15
Figure 16. Leading companies by number of COVID-19 drugs and vaccines in development as of September 3, 2021 17
Figure 17. Global Covid-19 Treatment Market Share by Players in 2020 22
Figure 18. The Top 5 Players Market Share by Covid-19 Treatment Revenue in 2020 25
Figure 19. North America Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 77
Figure 20. United States Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 80
Figure 21. Canada Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 81
Figure 22. Mexico Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 81
Figure 23. Europe Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 82
Figure 24. Germany Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 84
Figure 25. France Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 85
Figure 26. U.K. Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 85
Figure 27. Italy Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 86
Figure 28. Russia Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 86
Figure 29. Asia-Pacific Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 87
Figure 30. China Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 89
Figure 31. Japan Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 90
Figure 32. South Korea Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 91
Figure 33. Southeast Asia Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 92
Figure 34. India Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 93
Figure 35. South America Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 94
Figure 36. Brazil Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 96
Figure 37. Middle East & Africa Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 97
Figure 38. Middle East Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 99
Figure 39. Africa Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) 100
Figure 40. Bottom-up and Top-down Approaches for This Report 151
Figure 41. Data Triangulation 152
Figure 42. Key Executives Interviewed 154
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs